2,4-thiazolidinedione has been researched along with Dementia in 4 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The use of dipeptidyl peptidase-4 (DPP-4) inhibitors, metformin, thiazolidinedione, and sulfonylurea was associated with a decreased risk of dementia in comparison to no treatment with antidiabetic agents (hazard ratio [HR] for DPP-4 inhibitors, 0." | 5.05 | Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis. ( Han, M; Simó, R; Tang, X; Yang, J; Zhou, JB, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, H | 2 |
| Zhuo, L | 2 |
| Sun, Y | 2 |
| Shen, P | 2 |
| Lin, H | 2 |
| Zhan, S | 2 |
| Wasif, U | 1 |
| Al-Shehab, U | 1 |
| Lo, DF | 1 |
| Zhou, JB | 1 |
| Tang, X | 1 |
| Han, M | 1 |
| Yang, J | 1 |
| Simó, R | 1 |
1 review available for 2,4-thiazolidinedione and Dementia
| Article | Year |
|---|---|
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
Topics: Bayes Theorem; Dementia; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypo | 2020 |
3 other studies available for 2,4-thiazolidinedione and Dementia
| Article | Year |
|---|---|
Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study.
Topics: Dementia; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Re | 2023 |
Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes.
Topics: Dementia; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Thiazolidinediones | 2023 |
Response to: Critical commentary on the association between thiazolidinedione use and dementia risk in patients with type 2 diabetes.
Topics: Dementia; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Thiazolidinediones | 2023 |